| Reaction Details |
|---|
 | Report a problem with these data |
| Target | LIM domain kinase 2 |
|---|
| Ligand | BDBM50044011 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_1445332 (CHEMBL3377887) |
|---|
| IC50 | 3.2±n/a nM |
|---|
| Citation |  Harrison, BA; Almstead, ZY; Burgoon, H; Gardyan, M; Goodwin, NC; Healy, J; Liu, Y; Mabon, R; Marinelli, B; Samala, L; Zhang, Y; Stouch, TR; Whitlock, NA; Gopinathan, S; McKnight, B; Wang, S; Patel, N; Wilson, AG; Hamman, BD; Rice, DS; Rawlins, DB Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma. ACS Med Chem Lett6:84-8 (2015) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| LIM domain kinase 2 |
|---|
| Name: | LIM domain kinase 2 |
|---|
| Synonyms: | LIMK2 | LIMK2_HUMAN |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 72238.81 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | ChEMBL_1514398 |
|---|
| Residue: | 638 |
|---|
| Sequence: | MSALAGEDVWRCPGCGDHIAPSQIWYRTVNETWHGSCFRCSECQDSLTNWYYEKDGKLYC
PKDYWGKFGEFCHGCSLLMTGPFMVAGEFKYHPECFACMSCKVIIEDGDAYALVQHATLY
CGKCHNEVVLAPMFERLSTESVQEQLPYSVTLISMPATTEGRRGFSVSVESACSNYATTV
QVKEVNRMHISPNNRNAIHPGDRILEINGTPVRTLRVEEVEDAISQTSQTLQLLIEHDPV
SQRLDQLRLEARLAPHMQNAGHPHALSTLDTKENLEGTLRRRSLRRSNSISKSPGPSSPK
EPLLFSRDISRSESLRCSSSYSQQIFRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMK
ELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSM
DPFPWQQKVRFAKGIASGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEER
KRAPMEKATTKKRTLRKNDRKKRYTVVGNPYWMAPEMLNGKSYDETVDIFSFGIVLCEII
GQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCRLEPESRPAFSKLEDS
FEALSLYLGELGIPLPAELEELDHTVSMQYGLTRDSPP
|
|
|
|---|
| BDBM50044011 |
|---|
| n/a |
|---|
| Name | BDBM50044011 |
|---|
| Synonyms: | CHEMBL3356425 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C24H31N5O |
|---|
| Mol. Mass. | 405.5358 |
|---|
| SMILES | Cc1c[nH]c2ncnc(N3CCC(C)(CC3)C(=O)Nc3cccc(c3)C(C)(C)C)c12 |
|---|
| Structure | 
|
|---|
Search and Browse
